Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H22N2O5S |
Molecular Weight | 378.443 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](CC)OC3=CC=CC=C3)C(O)=O
InChI
InChIKey=HOCWPKXKMNXINF-RSUWNVLCSA-N
InChI=1S/C18H22N2O5S/c1-4-11(25-10-8-6-5-7-9-10)14(21)19-12-15(22)20-13(17(23)24)18(2,3)26-16(12)20/h5-9,11-13,16H,4H2,1-3H3,(H,19,21)(H,23,24)/t11-,12+,13-,16+/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6421744Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/2158301 | https://www.ncbi.nlm.nih.gov/pubmed/13909124 | https://www.ncbi.nlm.nih.gov/pubmed/13863272
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6421744
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/2158301 | https://www.ncbi.nlm.nih.gov/pubmed/13909124 | https://www.ncbi.nlm.nih.gov/pubmed/13863272
Levopropylcillin – is a penicillin derivative, L-enantiomer of antibiotic Propicillin. Levopropylcillin properties are similar to benzylpenicillin particularly used in streptococcal infections, not resistant to penicillinase. Levopropylcillin is acid resistant and can be used orally as the potassium salt.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4114 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2158301 |
|||
Target ID: GO:0031506 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | propicillin Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6421744
The patients received 1 Mega unit (0.7 g) propicillin orally as oblong tablets one or two hours before surgery.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1952836
Mixed continuous cultures of periodontal bacteria were obtained from the enrichment of subgingival plaque by using human serum as a growth medium. After stabilization of the culture by
15 volume changes, a single dose of propicillin, which was dissolved in 0.5 ml of water to give a final concentration of 1 mg/liter in the vessel, was added to the experimental culture. Two subsequent doses of 1 mg/liter were given at 24-h intervals, that is, after 2.4 volume changes, during which the concentration of propicillin in the vessel dropped by dilution until it was approximately 10o of the original value. One day (24 h) after the last addition, a sample was taken from the culture for microbiological analyses. Higher concentrations of propicillin were tested in experimental cultures that were obtained by transferring 2.5 ml from the control culture to a new vessel and then adding serum to a final volume of 5 ml. After batch growth for 24 h, the culture was switched to continuous growth, and after stabilization for 5 to 10 volume changes, the culture was exposed to 5, 10, or 50 mg of propicillin per liter added in a single dose. The addition of antibiotic was repeated after 24 h. Samples for microbiological analyses were taken 24 h after the second addition of propicillin.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1500
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1323
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
PRIMARY | |||
|
C83881
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
PRIMARY | |||
|
100000082281
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
PRIMARY | |||
|
EVM0146RSP
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL2111179
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
PRIMARY | |||
|
172994
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
PRIMARY | |||
|
SUB08485MIG
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
PRIMARY | |||
|
3736-12-7
Created by
admin on Sat Dec 16 17:04:07 GMT 2023 , Edited by admin on Sat Dec 16 17:04:07 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)